Pharma giant Pfizer has filed patent infringement suit against various generic players, who have filed ANDA with Para IV certification against Orange Book listed patents for neuropathic pain treatment Pregabalin (Lyrica) 25, 50, 75, 100, 150, 200, 225, 300 mg/capsule.
The lawsuit was filed on April 29, 2009 in Delaware District Court
Please read full article on following link:
http://genericpatentology.blogspot.com/2009/05/pregabalin-s-3-aminomethyl-5.html
No comments:
Post a Comment